Statute of Limitations
New Jersey: 2 years from discovery (N.J.S.A. 2A:14-2)
2 years from BIA-ALCL diagnosis or discovery of BIOCELL injury connection
Where to File in New Jersey
MDL 2921 — In re Allergan BIOCELL Textured Breast Implant Products Liability Litigation — is consolidated in the U.S. District Court for the District of New Jersey before the Honorable Brian R. Martinotti. New Jersey is both the MDL forum state and an active plaintiff state with its own cosmetic surgery market in northern New Jersey, the Jersey Shore, and the New York metropolitan area suburbs. New Jersey has a 2-year personal injury statute under N.J.S.A. 2A:14-2 with the discovery rule. Mediation sessions between Allergan/AbbVie and plaintiffs' leadership were ongoing through late 2025. The first bellwether trial is scheduled for October 2026. New Jersey plastic surgeons placed significant BIOCELL products from 2005–2019 in northern New Jersey and the Shore area. New Jersey BIA-ALCL patients have the most direct access to MDL 2921 proceedings.
Exposure in New Jersey
Source: MDL 2921 Docket, U.S. District Court, D.N.J.
Source: FDA MAUDE Adverse Event Database, June 2023
Your Legal Team
Patricia Osei-Bonsu
Senior Partner
Newark, NJ
Patricia Osei-Bonsu has spent 22 years representing plaintiffs in medical device mass tort litigation, with a particular concentration in New Jersey federal courts — the home jurisdiction of MDL 2921. Her biomedical engineering background gives her a technical fluency in breast implant design, surface texture specifications, and the biomechanical basis of the BIA-ALCL inflammatory hypothesis that is invaluable in deposing Allergan's engineers and medical experts. Patricia has represented over 150 BIA-ALCL and breast implant illness claimants in MDL 2921 proceedings and maintains close coordination with the MDL Plaintiffs' Steering Committee to keep clients informed of bellwether developments, case management orders, and settlement timeline. She has recovered over $65 million for medical device injury clients in her career.
Education
- J.D., Rutgers Law School (2004)
- B.S., Biomedical Engineering, New Jersey Institute of Technology (2001)